Knowledge

Osmotic-controlled release oral delivery system

Source 📝

1479: 1113: 111: 162: 1586: 238: 1826: 1107: 20: 1648: 1352: 228:
profiles were evaluated and tested in an attempt to determine the optimal way to deliver the drug, which was especially important given the puzzling failure of an existing extended-release formulation of methylphenidate (Ritalin SR) to act as expected. The zero-order (flat) release profile that the
233:
that an ascending pattern of drug delivery was necessary to maintain clinical effect. Trials designed to test this hypothesis were successful, and ALZA subsequently developed a modified PPOP design that utilized an overcoat of methylphenidate designed to release immediately and rapidly raise serum
234:
levels, followed by 10 hours of first-order (ascending) drug delivery from the modified PPOP design. This design was called the Push-Stick Osmotic Pump (PSOP), and utilized two separate drug layers with different concentrations of methylphenidate in addition to the (now quite robust) push layer.
140:
later developed the Controlled-Porosity Osmotic Pump (CPOP) with the intention of addressing some of the issues that led to Osmosin's withdrawal via a new approach to the final stage of the release mechanism. Unlike the EOP, the CPOP had no pre-formed hole in the outer shell for the drug to be
23:
A 54 mg tablet of Concerta, which uses OROS technology. 22% of the drug is contained in the red overcoat, while the remaining 78% is split between two drug layers of differing concentration. The tablet uses an additional push layer that expands as water enters the tablet via the osmotic
93:, and differing intestinal environments. Using an osmotic pump to deliver drugs has additional inherent advantages regarding control over drug delivery rates. This allows for much more precise drug delivery over an extended period of time, which results in much more predictable 229:
PPOP was optimal at delivering failed to maintain its efficacy over time, which suggested that acute tolerance to methylphenidate formed over the course of the day. This explained why Ritalin SR was inferior to twice-daily Ritalin IR, and led to the
141:
expelled out of. Instead, the CPOP's semipermeable membrane was designed to form numerous small pores upon contact with water through which the drug would be expelled via osmotic pressure. The pores were formed via the use of a pH insensitive
97:. However, osmotic release systems are relatively complicated, somewhat difficult to manufacture, and may cause irritation or even blockage of the GI tract due to prolonged release of irritating drugs from the non-deformable tablet. 658:
van den Berg, G; van Steveninck, F; Gubbens-Stibbe, JM; Schoemaker, HC; de Boer, AG; Cohen, AF (1990). "Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers".
791:
Auiler, JF; Liu, K; Lynch, JM; Gelotte, CK (2002). "Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study".
205: 1024: 967:"Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies" 122:
in 1974, and was the first practical example of an osmotic pump based drug release system for oral use. It was introduced to the market in the early 1980s in Osmosin (
1870: 748:
Modi, NB; Wang, B; Hu, WT; Gupta, SK (January 2000). "Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects".
521:
Conley, R; Gupta, SK; Sathyan, G (October 2006). "Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form".
224:
required multiple doses to be administered each day to attain long-lasting coverage, which made it an ideal candidate for the OROS technology. Multiple candidate
85:
Osmotic release systems have a number of major advantages over other controlled-release mechanisms. They are significantly less affected by factors such as
1017: 705:
Bass, DM; Prevo, M; Waxman, DS (2002). "Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study".
1010: 427:
Malaterre, V; Ogorka, J; Loggia, N; Gurny, R (November 2009). "Oral osmotically driven systems: 30 years of development and clinical use".
217: 197:. The initial design developed in 1982 by ALZA researchers was designated the Push-Pull Osmotic Pump (PPOP), and Procardia XL ( 761: 45: 1381: 1964: 181:
polymer for suspension of poorly soluble drugs) out of the exit hole at a controlled rate. Osmotic agents such as
90: 1969: 1462: 467:
Theeuwes, F; Yum, SI; Haak, R; Wong, P (1991). "Systems for triggered, pulsed, and programmed drug delivery".
1559: 1402: 173:
drugs. This led to the development of an additional internal "push layer" composed of material (a swellable
169:
Both the EOP and CPOP were relatively simple designs, and were limited by their inability to deliver poorly
1933: 1895: 1238: 1054: 131: 869:
Eckenhoff, B; Yum, SI (April 1981). "The osmotic pump: novel research tool for optimizing drug regimens".
1847: 965:
Swanson, J; Gupta, S; Lam, A; Shoulson, I; Lerner, M; Modi, N; Lindemulder, E; Wigal, S (February 2003).
208:
An animation illustrating the exterior/interior compositions of a tablet of Concerta, a PSOP OROS design.
1875: 1444: 1989: 1923: 1852: 1439: 1386: 1220: 1478: 1842: 1216: 1913: 1880: 1834: 1679: 1511: 1243: 1164: 1091: 1033: 177:) that would expand as it absorbed water, which then pushed the drug layer (which incorporates a 146: 33: 24:
membrane. The drug is expelled via the laser-drilled hole visible on the left side of the tablet.
1908: 1862: 1804: 1710: 1577: 1184: 1058: 65: 49: 241:
An illustration of the different inner components of a tablet of Concerta, a PSOP OROS design.
1984: 1974: 1918: 1799: 1212: 1979: 1763: 1608: 1526: 1471: 1391: 1376: 1179: 476: 142: 212:
In the early 1990s, an ALZA-funded research program began to develop a new dosage form of
8: 1816: 1553: 1434: 1429: 1149: 1045: 1002: 256: 127: 615:
Verma, RK; Mishra, B; Garg, S (July 2000). "Osmotically controlled oral drug delivery".
480: 1890: 1684: 1639: 1336: 1081: 816: 773: 730: 684: 640: 546: 500: 488: 186: 1740: 1735: 1573: 1314: 1076: 988: 917: 886: 882: 851: 808: 765: 722: 718: 676: 632: 594: 538: 492: 444: 37: 820: 777: 734: 644: 550: 504: 1674: 978: 909: 878: 843: 800: 757: 714: 688: 668: 624: 584: 530: 484: 436: 324: 225: 194: 94: 69: 57: 657: 110: 1564: 1248: 1112: 370: 328: 320: 316: 312: 284: 213: 182: 161: 1625: 1258: 804: 440: 137: 41: 983: 966: 936: 913: 1958: 1768: 1690: 1659: 1424: 1253: 534: 377: 335: 1809: 1745: 1730: 1705: 1543: 1263: 992: 847: 812: 769: 726: 636: 598: 542: 448: 349: 123: 114:
An illustration of the different components of the Elementary Osmotic Pump.
921: 890: 680: 628: 496: 165:
An illustration of the different components of the Push-Pull Osmotic Pump.
1903: 1791: 1664: 1620: 1598: 1585: 1516: 1486: 1420: 1269: 1208: 1037: 204: 237: 1825: 1787: 1758: 1318: 1292: 1154: 855: 672: 384: 363: 305: 298: 263: 230: 198: 170: 1106: 1397: 1287: 1139: 1129: 342: 291: 277: 221: 178: 19: 589: 572: 1939: 1928: 1720: 1700: 1695: 1669: 1613: 1506: 1496: 1491: 1194: 1159: 1144: 1086: 762:
10.1002/1099-081x(200001)21:1<23::aid-bdd212>3.0.co;2-v
573:"Osmotically controlled drug delivery system with associated drugs" 356: 270: 150: 72:, which pioneered the use of osmotic pumps for oral drug delivery. 130:), but unexpectedly severe issues with GI irritation and cases of 1725: 1654: 1593: 1538: 1533: 1501: 1341: 1297: 1174: 904:
Heimlich, KR (1983). "The evolution of precision drug delivery".
190: 174: 53: 1647: 64:
through the laser drilled opening(s) in the tablet and into the
1715: 1635: 1548: 1368: 1279: 1169: 1134: 1121: 1603: 1328: 1230: 1189: 1068: 571:
Gupta, BP; Thakur, N; Jain, NP; Banweer, J; Jain, S (2010).
193:
are added to both the drug and push layers to increase the
119: 61: 40:
with a semi-permeable outer membrane and one or more small
1351: 1032: 426: 201:) was one of the first drugs to utilize this PPOP design. 1467: 1412: 834:
Theeuwes, F (December 1975). "Elementary osmotic pump".
964: 86: 570: 429:
European Journal of Pharmaceutics and Biopharmaceutics
30:
osmotic-controlled release oral delivery system (OROS)
790: 16:
Advanced controlled release oral drug delivery system
466: 118:The Elementary Osmotic Pump (EOP) was developed by 520: 577:Journal of Pharmacy & Pharmaceutical Sciences 36:oral drug delivery system in the form of a rigid 1956: 960: 958: 747: 704: 614: 422: 100: 700: 698: 610: 608: 566: 564: 562: 560: 516: 514: 420: 418: 416: 414: 412: 410: 408: 406: 404: 402: 1018: 462: 460: 458: 955: 868: 943:. United States Patent and Trademark Office 897: 862: 784: 741: 695: 605: 557: 511: 399: 245: 1025: 1011: 651: 469:Annals of the New York Academy of Sciences 455: 982: 661:European Journal of Clinical Pharmacology 588: 903: 833: 827: 617:Drug Development and Industrial Pharmacy 236: 218:attention deficit hyperactivity disorder 203: 160: 109: 18: 750:Biopharmaceutics & Drug Disposition 1957: 934: 68:. OROS is a trademarked name owned by 1006: 906:Current Medical Research and Opinion 793:Current Medical Research and Opinion 523:Current Medical Research and Opinion 1382:Heated humidified high-flow therapy 216:for the treatment of children with 13: 1646: 1584: 1477: 937:"Controlled porosity osmotic pump" 836:Journal of Pharmaceutical Sciences 489:10.1111/j.1749-6632.1991.tb27262.x 134:led to the withdrawal of Osmosin. 14: 2001: 935:Haslam, John L.; Rork, Gerald S. 1824: 1350: 1111: 1105: 719:10.2165/00002018-200225140-00004 220:(ADHD). Methylphenidate's short 80: 48:, water is absorbed through the 928: 105: 971:Archives of General Psychiatry 156: 1: 1150:Effervescent powder or tablet 392: 1934:Patient-controlled analgesia 1239:Orally disintegrating tablet 883:10.1016/0142-9612(81)90005-3 101:Oral osmotic release systems 75: 7: 60:is used to push the active 44:holes in it. As the tablet 10: 2006: 1445:Relative analgesia machine 805:10.1185/030079902125000840 441:10.1016/j.ejpb.2009.07.002 250:OROS medications include: 1889: 1861: 1833: 1822: 1786: 1753: 1634: 1572: 1525: 1461: 1411: 1367: 1348: 1327: 1313: 1278: 1229: 1207: 1120: 1103: 1067: 1053: 1044: 984:10.1001/archpsyc.60.2.204 914:10.1185/03007998309109821 1034:Routes of administration 535:10.1185/030079906x132613 297:Ditropan XL/Lyrinel XL ( 246:List of OROS medications 1965:Pharmaceutical industry 1560:Extra-amniotic infusion 1165:Molecular encapsulation 1097:Osmotic delivery system 1092:Time release technology 46:passes through the body 1863:Central nervous system 1651: 1589: 1517:Mucoadhesive microdisc 1482: 848:10.1002/jps.2600641218 242: 209: 166: 115: 66:gastrointestinal tract 50:semipermeable membrane 25: 1970:Drug delivery devices 1706:Transfersome vesicles 1650: 1588: 1565:Intravesical infusion 1481: 629:10.1081/ddc-100101287 240: 207: 164: 113: 22: 1392:Metered-dose inhaler 1377:Anesthetic vaporizer 908:. 8 Suppl 2: 28–37. 56:, and the resulting 1817:Transdermal implant 1777:(into tissue/blood) 1554:Intrauterine device 1435:Anaesthetic machine 1430:Oxygen concentrator 481:1991NYASA.618..428T 257:phenylpropanolamine 128:phenylpropanolamine 1929:Nanocell injection 1652: 1590: 1483: 1337:Dry-powder inhaler 673:10.1007/bf00315121 243: 210: 187:potassium chloride 167: 116: 34:controlled release 26: 1952: 1951: 1948: 1947: 1779: 1741:Transdermal spray 1736:Transdermal patch 1726:Medicated shampoo 1457: 1456: 1453: 1452: 1440:Medical inhalants 1387:Medical inhalants 1315:Respiratory tract 1309: 1308: 1203: 1202: 334:Exalgo/Jurnista ( 149:additive such as 1997: 1990:Pharmacokinetics 1828: 1784: 1783: 1775: 1362: 1358: 1354: 1325: 1324: 1254:Sublingual drops 1227: 1226: 1115: 1109: 1065: 1064: 1051: 1050: 1027: 1020: 1013: 1004: 1003: 997: 996: 986: 962: 953: 952: 950: 948: 932: 926: 925: 901: 895: 894: 866: 860: 859: 831: 825: 824: 788: 782: 781: 745: 739: 738: 702: 693: 692: 655: 649: 648: 612: 603: 602: 592: 568: 555: 554: 518: 509: 508: 464: 453: 452: 424: 325:chlorpheniramine 195:osmotic pressure 95:pharmacokinetics 70:ALZA Corporation 58:osmotic pressure 2005: 2004: 2000: 1999: 1998: 1996: 1995: 1994: 1955: 1954: 1953: 1944: 1924:Intraperitoneal 1896:musculoskeletal 1894: 1885: 1857: 1853:Intra-articular 1829: 1820: 1780: 1774: 1773: 1749: 1630: 1568: 1521: 1466: 1449: 1407: 1363: 1360: 1359: 1356: 1355: 1346: 1305: 1274: 1199: 1116: 1110: 1101: 1055:Digestive tract 1040: 1031: 1001: 1000: 963: 956: 946: 944: 933: 929: 902: 898: 867: 863: 842:(12): 1987–91. 832: 828: 789: 785: 746: 742: 713:(14): 1021–33. 703: 696: 656: 652: 613: 606: 590:10.18433/j38w25 569: 558: 529:(10): 1879–92. 519: 512: 465: 456: 425: 400: 395: 390: 371:pseudoephedrine 329:pseudoephedrine 321:pseudoephedrine 317:brompheniramine 313:pseudoephedrine 285:methylphenidate 248: 226:pharmacokinetic 214:methylphenidate 183:sodium chloride 159: 138:Merck & Co. 126:) and Acutrim ( 108: 103: 89:, food intake, 83: 78: 32:is an advanced 17: 12: 11: 5: 2003: 1993: 1992: 1987: 1982: 1977: 1972: 1967: 1950: 1949: 1946: 1945: 1943: 1942: 1937: 1931: 1926: 1921: 1916: 1911: 1906: 1900: 1898: 1887: 1886: 1884: 1883: 1878: 1873: 1867: 1865: 1859: 1858: 1856: 1855: 1850: 1845: 1843:Intracavernous 1839: 1837: 1831: 1830: 1823: 1821: 1819: 1814: 1813: 1812: 1802: 1797: 1795: 1781: 1772: 1771: 1766: 1761: 1755: 1754: 1751: 1750: 1748: 1743: 1738: 1733: 1728: 1723: 1718: 1713: 1708: 1703: 1698: 1693: 1688: 1682: 1677: 1672: 1667: 1662: 1657: 1645: 1643: 1632: 1631: 1629: 1628: 1626:Nutrient enema 1623: 1618: 1617: 1616: 1611: 1601: 1596: 1583: 1581: 1570: 1569: 1567: 1562: 1557: 1551: 1546: 1541: 1536: 1531: 1529: 1523: 1522: 1520: 1519: 1514: 1509: 1504: 1499: 1494: 1489: 1476: 1474: 1459: 1458: 1455: 1454: 1451: 1450: 1448: 1447: 1442: 1437: 1432: 1427: 1417: 1415: 1409: 1408: 1406: 1405: 1400: 1395: 1389: 1384: 1379: 1373: 1371: 1365: 1364: 1349: 1347: 1345: 1344: 1339: 1333: 1331: 1322: 1311: 1310: 1307: 1306: 1304: 1303: 1300: 1295: 1290: 1284: 1282: 1276: 1275: 1273: 1272: 1267: 1261: 1256: 1251: 1246: 1241: 1235: 1233: 1224: 1205: 1204: 1201: 1200: 1198: 1197: 1192: 1187: 1182: 1177: 1172: 1167: 1162: 1157: 1152: 1147: 1142: 1137: 1132: 1126: 1124: 1118: 1117: 1104: 1102: 1100: 1099: 1094: 1089: 1084: 1079: 1073: 1071: 1062: 1048: 1042: 1041: 1030: 1029: 1022: 1015: 1007: 999: 998: 954: 941:Google Patents 927: 896: 861: 826: 783: 740: 694: 650: 623:(7): 695–708. 604: 556: 510: 454: 397: 396: 394: 391: 389: 388: 381: 374: 367: 362:Procardia XL ( 360: 355:Minipress XL ( 353: 346: 341:Glucotrol XL ( 339: 332: 309: 302: 295: 288: 281: 274: 267: 260: 252: 247: 244: 158: 155: 132:GI perforation 107: 104: 102: 99: 82: 79: 77: 74: 15: 9: 6: 4: 3: 2: 2002: 1991: 1988: 1986: 1983: 1981: 1978: 1976: 1973: 1971: 1968: 1966: 1963: 1962: 1960: 1941: 1938: 1935: 1932: 1930: 1927: 1925: 1922: 1920: 1917: 1915: 1914:Intramuscular 1912: 1910: 1907: 1905: 1902: 1901: 1899: 1897: 1892: 1888: 1882: 1879: 1877: 1874: 1872: 1871:Intracerebral 1869: 1868: 1866: 1864: 1860: 1854: 1851: 1849: 1846: 1844: 1841: 1840: 1838: 1836: 1832: 1827: 1818: 1815: 1811: 1808: 1807: 1806: 1803: 1801: 1798: 1796: 1793: 1789: 1785: 1782: 1778: 1770: 1767: 1765: 1762: 1760: 1757: 1756: 1752: 1747: 1744: 1742: 1739: 1737: 1734: 1732: 1729: 1727: 1724: 1722: 1719: 1717: 1714: 1712: 1709: 1707: 1704: 1702: 1699: 1697: 1694: 1692: 1691:Iontophoresis 1689: 1686: 1683: 1681: 1678: 1676: 1673: 1671: 1668: 1666: 1663: 1661: 1660:Topical cream 1658: 1656: 1653: 1649: 1644: 1641: 1637: 1633: 1627: 1624: 1622: 1619: 1615: 1612: 1610: 1607: 1606: 1605: 1602: 1600: 1597: 1595: 1592: 1591: 1587: 1582: 1579: 1575: 1571: 1566: 1563: 1561: 1558: 1555: 1552: 1550: 1547: 1545: 1542: 1540: 1537: 1535: 1532: 1530: 1528: 1524: 1518: 1515: 1513: 1510: 1508: 1505: 1503: 1500: 1498: 1495: 1493: 1490: 1488: 1485: 1484: 1480: 1475: 1473: 1469: 1464: 1460: 1446: 1443: 1441: 1438: 1436: 1433: 1431: 1428: 1426: 1425:Nasal cannula 1422: 1419: 1418: 1416: 1414: 1410: 1404: 1401: 1399: 1396: 1393: 1390: 1388: 1385: 1383: 1380: 1378: 1375: 1374: 1372: 1370: 1366: 1353: 1343: 1340: 1338: 1335: 1334: 1332: 1330: 1326: 1323: 1320: 1316: 1312: 1301: 1299: 1296: 1294: 1291: 1289: 1286: 1285: 1283: 1281: 1277: 1271: 1268: 1265: 1262: 1260: 1257: 1255: 1252: 1250: 1247: 1245: 1242: 1240: 1237: 1236: 1234: 1232: 1228: 1225: 1222: 1218: 1214: 1210: 1206: 1196: 1193: 1191: 1188: 1186: 1183: 1181: 1178: 1176: 1173: 1171: 1168: 1166: 1163: 1161: 1158: 1156: 1153: 1151: 1148: 1146: 1143: 1141: 1138: 1136: 1133: 1131: 1128: 1127: 1125: 1123: 1119: 1114: 1108: 1098: 1095: 1093: 1090: 1088: 1085: 1083: 1080: 1078: 1075: 1074: 1072: 1070: 1066: 1063: 1060: 1056: 1052: 1049: 1047: 1043: 1039: 1035: 1028: 1023: 1021: 1016: 1014: 1009: 1008: 1005: 994: 990: 985: 980: 977:(2): 204–11. 976: 972: 968: 961: 959: 942: 938: 931: 923: 919: 915: 911: 907: 900: 892: 888: 884: 880: 876: 872: 865: 857: 853: 849: 845: 841: 837: 830: 822: 818: 814: 810: 806: 802: 798: 794: 787: 779: 775: 771: 767: 763: 759: 755: 751: 744: 736: 732: 728: 724: 720: 716: 712: 708: 701: 699: 690: 686: 682: 678: 674: 670: 666: 662: 654: 646: 642: 638: 634: 630: 626: 622: 618: 611: 609: 600: 596: 591: 586: 583:(4): 571–88. 582: 578: 574: 567: 565: 563: 561: 552: 548: 544: 540: 536: 532: 528: 524: 517: 515: 506: 502: 498: 494: 490: 486: 482: 478: 475:(1): 428–40. 474: 470: 463: 461: 459: 450: 446: 442: 438: 435:(3): 311–23. 434: 430: 423: 421: 419: 417: 415: 413: 411: 409: 407: 405: 403: 398: 386: 382: 379: 378:carbamazepine 376:Tegretol XR ( 375: 372: 368: 365: 361: 358: 354: 351: 347: 344: 340: 337: 336:hydromorphone 333: 330: 326: 322: 318: 314: 310: 307: 304:Dynacirc CR ( 303: 300: 296: 293: 289: 286: 282: 279: 275: 272: 268: 265: 262:Adalat OROS ( 261: 258: 254: 253: 251: 239: 235: 232: 227: 223: 219: 215: 206: 202: 200: 196: 192: 188: 184: 180: 176: 172: 163: 154: 152: 148: 144: 139: 135: 133: 129: 125: 121: 112: 98: 96: 92: 88: 81:Pros and cons 73: 71: 67: 63: 59: 55: 51: 47: 43: 42:laser drilled 39: 35: 31: 21: 1985:Pharmacology 1975:Dosage forms 1919:Intraosseous 1909:Intracardiac 1848:Intravitreal 1810:Injector pen 1805:Subcutaneous 1776: 1746:Jet injector 1731:Dermal patch 1544:Vaginal ring 1512:Insufflation 1264:Effervescent 1096: 1038:dosage forms 974: 970: 945:. Retrieved 940: 930: 905: 899: 877:(2): 89–97. 874: 871:Biomaterials 870: 864: 839: 835: 829: 799:(5): 311–6. 796: 792: 786: 756:(1): 23–31. 753: 749: 743: 710: 706: 667:(3): 315–6. 664: 660: 653: 620: 616: 580: 576: 526: 522: 472: 468: 432: 428: 369:Sudafed 24 ( 350:paliperidone 276:Cardura XL ( 269:Alpress LP ( 249: 211: 168: 136: 124:indomethacin 117: 106:Single-layer 84: 29: 27: 1980:Alza brands 1904:Intravenous 1891:Circulatory 1876:Intrathecal 1800:Intradermal 1792:transdermal 1759:Parenterals 1665:Topical gel 1621:Murphy drip 1599:Suppository 1487:Nasal spray 1421:Oxygen mask 1270:Chewing gum 1209:Oral mucosa 707:Drug Safety 311:Efidac 24 ( 290:Covera HS ( 157:Multi-layer 147:dissolvable 91:GI motility 1959:Categories 1764:Injections 1527:Urogenital 1463:Ophthalmic 1319:inhalation 1293:Toothpaste 1221:sublingual 1185:Suspension 1155:Herbal tea 393:References 385:salbutamol 364:nifedipine 306:isradipine 299:oxybutynin 283:Concerta ( 264:nifedipine 231:hypothesis 199:nifedipine 1769:infusions 1701:Liposomes 1497:Eye drops 1492:Ear drops 1403:Vaporizer 1398:Nebulizer 1288:Mouthwash 1217:sublabial 1140:Electuary 1130:Decoction 343:glipizide 292:verapamil 278:doxazosin 255:Acutrim ( 222:half-life 143:leachable 76:Rationale 1940:PIC line 1881:Epidural 1721:Lip balm 1696:Hydrogel 1687:solution 1670:Liniment 1655:Ointment 1614:Hydrogel 1609:Solution 1594:Ointment 1534:Ointment 1507:Hydrogel 1502:Ointment 1298:Ointment 1259:Lozenges 1249:Lollipop 1195:Tincture 1180:Solution 1160:Hydrogel 1145:Emulsion 1087:Pastille 993:12578439 947:19 March 821:25994524 813:12240794 778:33413277 770:11038435 735:35424637 727:12408733 645:35670161 637:10872087 599:21486532 551:42490425 543:17022845 505:31442663 449:19602438 383:Volmax ( 357:prazosin 348:Invega ( 271:prazosin 151:sorbitol 1640:topical 1578:enteral 1539:Pessary 1369:Liquids 1342:Smoking 1280:Liquids 1175:Softgel 1122:Liquids 1082:Capsule 1059:enteral 922:6851623 891:7248427 689:1838636 681:2257873 497:2006800 477:Bibcode 191:xylitol 179:viscous 175:polymer 171:soluble 54:osmosis 1835:Organs 1716:Lotion 1636:Dermal 1574:Rectal 1549:Douche 1329:Solids 1266:tablet 1231:Solids 1213:buccal 1170:Powder 1135:Elixir 1077:Tablet 1069:Solids 991:  920:  889:  854:  819:  811:  776:  768:  733:  725:  687:  679:  643:  635:  597:  549:  541:  503:  495:  447:  38:tablet 1711:Cream 1675:Paste 1604:Enema 1556:(IUD) 1472:nasal 1394:(MDI) 1302:Spray 1190:Syrup 817:S2CID 774:S2CID 731:S2CID 685:S2CID 641:S2CID 547:S2CID 501:S2CID 189:, or 1936:pump 1788:Skin 1685:DMSO 1680:Film 1468:otic 1423:and 1244:Film 1046:Oral 989:PMID 949:2016 918:PMID 887:PMID 856:1510 852:PMID 809:PMID 766:PMID 723:PMID 677:PMID 633:PMID 595:PMID 539:PMID 493:PMID 445:PMID 120:ALZA 62:drug 52:via 28:The 1413:Gas 979:doi 910:doi 879:doi 844:doi 801:doi 758:doi 715:doi 669:doi 625:doi 585:doi 531:doi 485:doi 473:618 437:doi 145:or 1961:: 1470:, 1219:, 1215:, 1036:, 987:. 975:60 973:. 969:. 957:^ 939:. 916:. 885:. 873:. 850:. 840:64 838:. 815:. 807:. 797:18 795:. 772:. 764:. 754:21 752:. 729:. 721:. 711:25 709:. 697:^ 683:. 675:. 665:39 663:. 639:. 631:. 621:26 619:. 607:^ 593:. 581:13 579:. 575:. 559:^ 545:. 537:. 527:22 525:. 513:^ 499:. 491:. 483:. 471:. 457:^ 443:. 433:73 431:. 401:^ 327:, 319:, 185:, 153:. 87:pH 1893:, 1794:) 1790:( 1642:) 1638:( 1580:) 1576:( 1465:, 1361:0 1357:0 1321:) 1317:( 1223:) 1211:( 1061:) 1057:( 1026:e 1019:t 1012:v 995:. 981:: 951:. 924:. 912:: 893:. 881:: 875:2 858:. 846:: 823:. 803:: 780:. 760:: 737:. 717:: 691:. 671:: 647:. 627:: 601:. 587:: 553:. 533:: 507:. 487:: 479:: 451:. 439:: 387:) 380:) 373:) 366:) 359:) 352:) 345:) 338:) 331:) 323:/ 315:/ 308:) 301:) 294:) 287:) 280:) 273:) 266:) 259:)

Index


controlled release
tablet
laser drilled
passes through the body
semipermeable membrane
osmosis
osmotic pressure
drug
gastrointestinal tract
ALZA Corporation
pH
GI motility
pharmacokinetics

ALZA
indomethacin
phenylpropanolamine
GI perforation
Merck & Co.
leachable
dissolvable
sorbitol

soluble
polymer
viscous
sodium chloride
potassium chloride
xylitol

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.